Hydrochloric Acid → (R)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide hydrochloride

HRID 2275330Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2275330
CO.[F:3][C:4]1[CH:9]=[CH:8][C:7]([F:10])=[CH:6][C:5]=1[C@H:11]1[CH2:15][CH2:14][CH2:13][N:12]1[C:16]1[CH:21]=[CH:20][N:19]2[N:22]=[CH:23][C:24]([NH:25][C:26]([N:28]3[CH2:31][CH:30]([OH:32])[CH2:29]3)=[O:27])=[C:18]2[N:17]=1.[ClH:33]>O1CCOCC1>[ClH:33].[F:3][C:4]1[CH:9]=[CH:8][C:7]([F:10])=[CH:6][C:5]=1[C@H:11]1[CH2:15][CH2:14][CH2:13][N:12]1[C:16]1[CH:21]=[CH:20][N:19]2[N:22]=[CH:23][C:24]([NH:25][C:26]([N:28]3[CH2:31][CH:30]([OH:32])[CH2:29]3)=[O:27])=[C:18]2[N:17]=1

Komponenten

5

Versuchsvorschrift

To a methanol (1 mL) solution of (R)—N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide (5.2 mg, 0.013 mmol) was added HCl as a solution is dioxane (30 μL). After 30 minutes, the reaction was concentrated to provide (R)—N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide hydrochloride (5.7 mg, 0.013 mmol, 101% yield) as a yellow solid.

Aufarbeitung

  1. concentrationthe reaction was concentrated

Quellen und Nachweise

ORD-Eintrag
ord-6c80a3ee896649fb97fa606bad2728a5
Quelldatensatz
uspto-grants-2015_09
Patentnummer
US09127013B2

Notizen zur Reaktion

Wird geladen…